Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study

We conducted a multicenter, retrospective study to evaluate the efficacy and safety of combination nivolumab plus ipilimumab (NIVO+IPI) in 35 patients with advanced or metastatic renal cell carcinoma (mRCC). In this study, we focused on patients who received NIVO+IPI and were stratified into interme...

Descripción completa

Detalles Bibliográficos
Autores principales: Iinuma, Koji, Kameyama, Koji, Kawada, Kei, Fujimoto, Shota, Takagi, Kimiaki, Nagai, Shingo, Ito, Hiroki, Ishida, Takashi, Kawase, Makoto, Kawase, Kota, Nakai, Chie, Kato, Daiki, Takai, Manabu, Nakane, Keita, Koie, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167798/
https://www.ncbi.nlm.nih.gov/pubmed/33916792
http://dx.doi.org/10.3390/curroncol28020133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167798/
https://www.ncbi.nlm.nih.gov/pubmed/33916792
http://dx.doi.org/10.3390/curroncol28020133

Ejemplares similares